Pulmonary Cell News Volume 12.16 | Apr 27 2023

    0
    17








    2023-04-27 | PULCN 12.16


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 12.16 – 27 April, 2023
    TOP STORY

    Cloning a Profibrotic Stem Cell Variant in Idiopathic Pulmonary Fibrosis

    Investigators used single-cell cloning technologies to generate “libraries” of basal stem cells from the distal lungs of 16 patients with idiopathic pulmonary fibrosis and 10 controls.
    [Science Translational Medicine]

    Abstract
    Scientific resources to support your organoids research. Learn More!
    PUBLICATIONSRanked by the impact factor of the journal

    Advanced Pathophysiology Mimicking Lung Models for Accelerated Drug Discovery

    To establish models that mimic lung complexity to different extents, researchers used five design components: cell type, membrane structure/constitution, environmental conditions, cellular arrangement, substrate, matrix structure, and composition.
    [Biomaterials Research]

    Full ArticleGraphical Abstract

    Rhinovirus C15 Attenuates Relaxation and cAMP Production in Human Airways and Smooth Muscle

    Utilizing human precision-cut lung slices, primary human air-liquid interface differentiated airway epithelial cells, and human airway smooth muscle as pre-clinical experimental models, scientists demonstrated that RV-C15 attenuated agonist-induced bronchodilation.
    [American Journal Of Respiratory Cell And Molecular Biology]

    Abstract

    Sirtuin 6 Ameliorates Bleomycin-Induced Pulmonary Fibrosis via Activation of Lipid Catabolism

    Researchers demonstrated that SIRT6 was predominantly expressed in alveolar epithelial cells in human lung tissues by using a single-cell sequencing database.
    [Journal Of Cellular Physiology]

    Abstract

    The Pro-Inflammatory Response to Influenza a Virus Infection Is Fueled by Endothelial Cells

    Investigators developed a transwell system in which airway organoid–derived differentiated human lung epithelial cells were co-cultured with primary human lung microvascular endothelial cells.
    [Life Science Alliance]

    Full Article

    MYC Drives Platinum Resistant SCLC That Is Overcome by the Dual PI3K-HDAC Inhibitor Fimepinostat

    Elevated MYC expression following the acquisition of platinum resistance in vitro and in vivo was assessed. The capacity of enforced MYC expression to drive platinum resistance was defined in small-cell lung cancer cell lines and in a genetically engineered mouse model that expresses MYC specifically in lung tumors.
    [Journal Of Experimental & Clinical Cancer Research]

    Full Article

    Dasatinib in Combination with BMS-754807 Induce Synergistic Cytotoxicity in Lung Cancer Cells through Inhibiting Lung Cancer Cell Growth, and Inducing Autophagy as Well as Cell Cycle Arrest at the G1 Phase

    The authors demonstrated that dasatinib in combination with BMS-754807 inhibited lung cancer cell growth, while induced autophagy as well as cell cycle arrest at the G1 phase.
    [Investigational New Drugs]

    Abstract

    Wee1 Epigenetically Modulates H2B Mono-Ubiquitination at K120 Lysine and DNA Double-Strand Break Repair through Phosphorylation of H2BY37-Dependent Manner in Small-Cell Lung Cancer

    Researchers determined the nonclassical mechanism of Wee1 on DNA repair regulation. Western blot was conducted to determine the mono-ubiquitination level of H2Bub.
    [Thoracic Cancer]

    Full Article

    Nimbolide Exhibits Potent Anticancer Activity through ROS-Mediated ER Stress and DNA Damage in Human Non-Small Cell Lung Cancer Cells

    The authors investigated the effects of nimbolide (NB) on A549 human NSCLC cells. They found that NB treatment inhibits A549 cells colony formation in a dose-dependent manner.
    [Applied Biochemistry And Biotechnology]

    Abstract
    How is drug screening being revolutionized for cystic fibrosis? With organoids. Watch Sylvia Boj's webinar.
    REVIEWS

    Targeting Neddylation as a Novel Approach to Lung Cancer Treatment

    Investigators review summarizes the regulatory roles of NEDD8 in the MDM2‑p53, NF‑κB, PI3K/AKT/mTOR, hypoxia‑inducible factor, Hippo and receptor tyrosine kinase signaling pathways, as well as in the development and progression of lung cancer.
    [International Journal Of Oncology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Bridge Bio Wins FDA Nod for Phase I/II Trial of NSCLC Treatment

    Biotherapeutics has obtained approval for its investigational new drug plan to conduct Phase I.II clinical trial of the fourth-generation EGFR-mutant non-small cell lung cancer targeted agent, BBT-207, from the US FDA.
    [Bridge Bio]

    Press Release

    US Cancer Deaths Are Falling — but Not Fast Enough

    Models showed that death rates must decline faster to meet Cancer Moonshot’s goals to cut deaths in half in 25 years.
    [Nature News]

    News Article
    FEATURED EVENT

    CTTACC 2023

    May 9 – 11, 2023
    Scottsdale, Arizona, United States

    > See All Events

    JOB OPPORTUNITIES

    Staff Scientist – Murine Phenotyping Core

    National Institutes of Health – Bethesda, Maryland, United States

    Postdoctoral Fellow – Cancer Biology

    Wake Forest University – Winston Salem, North Carolina, United States

    Faculty Scientist Positions – Perioperative Medicine

    The University of Texas Health Science Center at Houston – Houston, Texas, United States

    Associate/Full Professor – Pulmonary Hypertension

    Indiana University – Indiana, Pennsylvania, United States

    Faculty Positions – Cancer Research

    Case Western Reserve University – Cleveland, Ohio, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter